Business Wire

LightCON Opens Global Pre-Registration for the New Game, Rise of Stars (ROS)

14.1.2022 09:00:00 EET | Business Wire | Press release

Share

The global pre-registration for Rise of Stars (ROS), a new mobile game being developed by LightCON, which is a subsidiary of WEMADE MAX (Co-CEOs: Hyunguk Chang, Gilhyung Lee) (KOSDAQ: 101730), was opened on the 13th (Thu.).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110006120/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

LightCON opened global pre-registration for Rise of Stars (ROS). ROS will provide Silthereum, a new game token, and the Warship Carrier to which NFT is applied. ROS will start global service during the first quarter of this year. (Graphic: Business Wire)

ROS is the first 4x blockchain game to be released on the WEMIX platform. Set on the vast universe, this game features elaborately designed warships and planets.

Players can enjoy battles to attack opponents and find planets containing rich resources in the galaxy in addition to drawing up strategies to expand their power through real-time massive warfare.

In particular, ROS will provide ‘Silthereum,’ a new game token, and the ‘Warship Carrier’ to which NFT is applied.

Silthereum is obtained through the exchange of ‘Silther Particles,’ which are game resources, and can be mined through the Warship Carrier only.

As Silther Particles can also be obtained through plundering among users, a fierce struggle to secure resources is expected to take place.

The global pre-registration is received on the Google Play and Apple App Store in all global regions excluding Korea and China, etc.

To celebrate the opening of global pre-registration, a number of events and the ROS NFT pre-sale will be started.

The first is an airdrop event. Among those who participate in the pre-registration and verify their participation in the official ROS Twitter, 100,000 users will be selected by lot to win a total of one million Silthereum tokens.

In addition, an event to provide approximately 1.2 million Silthereum tokens to all ROS NFT buyers and official community event participants by lot will be held.

The Warship Carrier with unique features is pre-sold through NFT application. It will be on sale in the format of random box on the WEMIX auction event page. The pre-sale will be held twice, the first from January 27 to February 3 and the second from February 10 to 17.

ROS will start global service with ‘ROS on WEMIX’ during the first quarter of this year.

- Rise of Stars YouTube link: https://youtu.be/nRwgDjGZCaM

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For LightCON
Wemade Co., Ltd.
Young Ahn
+82-2-3709-2065
ay2000@wemade.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Xylem Announces Segment Leadership Appointments30.6.2026 14:30:00 EEST | Press release

Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced two executive leadership appointments, effective July 1, both reporting to President and Chief Executive Officer Matthew Pine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630087773/en/ Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions at Xylem. Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions. Most recently, she served as EVP and President, Applied Water at Xylem. Emmerich joined Xylem in 2024 from Carrier Global Corporation (NYSE: CARR), where she was Vice President of Global Enterprise Solutions and held several senior leadership roles, including leading the Americas Commercial HVAC business and the Global Residential, Light Commercial, and VRF HVAC portfolio. Emmerich succeeds Mike McGann, who will serve as senior advisor to ensure a smooth and orderly tra

Strike Europe Secures Full MiCA Authorization, Unlocking Bitcoin Services Across All 27 EU Member States30.6.2026 14:29:00 EEST | Press release

Strike, a leading Bitcoin financial services company, today announced that its European entity, Zap (Strike) Europe Limited, has been authorized as a crypto-asset service provider by the Malta Financial Services Authority (MFSA) under the EU's Markets in Crypto-Assets Regulation (MiCA) and the Malta Markets in Crypto Assets Act (Cap. 647, laws of Malta) to provide crypto-asset services. The license enables millions of Europeans across all 27 EU member states to access Strike's suite of Bitcoin financial services under a single regulatory framework, replacing the patchwork of national regimes that previously governed the market. Strike has served eligible European customers since April 2024. The MFSA authorization makes that presence permanent and EU-wide, and positions the company among a small group of firms to complete the MiCA process to date. "Europe deserves a Bitcoin-only company focused on doing one thing well, not a multi-asset platform where Bitcoin is an afterthought," said J

OpZira, Inc. Welcomes Scott Thielman, PhD, as Vice President of Product Development30.6.2026 14:17:00 EEST | Press release

OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President of Product Development, effective May 1, 2026. Dr. Thielman brings a unique connection to OpZira’s origins. As Chief Technology Officer of Product Creation Studio, he directed the product development of LumiThera’s Valeda® Light Delivery System - the breakthrough photobiomodulation therapy for dry age-related macular degeneration whose acquisition by Alcon led to the creation of OpZira. His involvement with Valeda gives him firsthand knowledge of the science, clinical vision, and engineering decisions that shaped the technology platform from which OpZira was born. For more than 25 years, Dr. Thielman has directed the development of dozens of FDA-cleared medical devices across ophthalmology, neurostimulation, dermatology, urology, and surgical instrumentation, with partners including Olympus

L&T Technology Services Launches Ainfonix ™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 13:45:00 EEST | Press release

L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation initiatives. Ainfonix™ 4.0, developed in LTTS’ Sustainability segment, addresses this challenge by transforming engineering artifacts and multi-modal data into structured, asset-linked information

Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release

Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye